Tumor-Treating Fields in Glioblastomas: Past, Present, and Future

SIMPLE SUMMARY: Glioblastoma (GBM) is the most common malignant primary brain tumor. Although the standard of care, including maximal resection, concurrent radiotherapy with temozolomide (TMZ), and adjuvant TMZ, has largely improved the prognosis of these patients, the 5-year survival rate is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaopeng, Yang, Xin, Wu, Jiaming, Yang, Huiyu, Li, Yilin, Li, Junlin, Liu, Qianshu, Wu, Chen, Xing, Hao, Liu, Penghao, Wang, Yu, Hu, Chunhua, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367615/
https://www.ncbi.nlm.nih.gov/pubmed/35954334
http://dx.doi.org/10.3390/cancers14153669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367615/
https://www.ncbi.nlm.nih.gov/pubmed/35954334
http://dx.doi.org/10.3390/cancers14153669

Ejemplares similares